Wenjuan Zhou
Zhengzhou, 450018, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
DCN-type NEDD8 E3 ligases: Structure, biological function and small-molecule inhibitor.
Journal: Pharmacological research
Published: January 05, 2026
Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular block: a multicentre, randomised, double-blind, positive-controlled phase III trial.
Journal: British journal of anaesthesia
Published: September 01, 2024
Evaluation of HZX-960, a novel DCN1-UBC12 interaction inhibitor, as a potential antifibrotic compound for liver fibrosis.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: May 11, 2022
Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 29, 2021
Correction: Potent and specific MTH1 inhibitors targeting gastric cancer.
Journal: Cell death & disease
Published: October 17, 2020
Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.
Journal: Journal of medicinal chemistry
Published: September 30, 2020
PARP-1-regulated TNF-α expression in the dorsal root ganglia and spinal dorsal horn contributes to the pathogenesis of neuropathic pain in rats.
Journal: Brain, behavior, and immunity
Published: January 07, 2020
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.
Journal: Journal of medicinal chemistry
Published: June 04, 2019
Potent and specific MTH1 inhibitors targeting gastric cancer.
Journal: Cell death & disease
Published: October 16, 2018
Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I.
Journal: Antioxidants & redox signaling
Published: September 22, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026